These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 4188588
1. [Controlled experimental study of the relations between fibrinolytic acitivity and anticoagulant activity in evaluation of activators of fibrinolysis]. Cascone A, Lampugnani P. Minerva Med; 1969 Dec 12; 60(99 Suppl):5039-45. PubMed ID: 4188588 [No Abstract] [Full Text] [Related]
2. [Clinical evaluation of a fribrinolytic drug in an experimental cross-over study]. Bizzi B, Butti A. Minerva Med; 1969 Dec 12; 60(99 Suppl):5062-7. PubMed ID: 4188590 [No Abstract] [Full Text] [Related]
3. [Modifications of fibrinolysis and coagulation activity in arteriosclerotic patients treated with a polysulfoester of pentosan (SP-54). I]. Cajozzo A, Citarrella P, Malleo C. Boll Soc Ital Cardiol; 1971 Dec 12; 16(3):117-26. PubMed ID: 4110180 [No Abstract] [Full Text] [Related]
5. [Antilipemic and fibrinolytic activity of an extractive mucopolysaccharide in atherosclerotic disease]. Isidori A, Butti A, Rossi G. Minerva Med; 1969 Dec 12; 60(99 Suppl):5077-81. PubMed ID: 4188592 [No Abstract] [Full Text] [Related]
6. [Effect of pyridinolcarbamate on blood coagulation and thrombolysis in patients with arteriosclerosis obliterans]. Hess H, Goossens N, Keil-Kuri E, Zollner R, Meyer A. Vasa; 1972 Dec 12; 1(3):206-11. PubMed ID: 5076123 [No Abstract] [Full Text] [Related]
7. [Current state of anticoagulant and fibrinolytic therapy]. Hladovec J. Cas Lek Cesk; 1971 Oct 15; 110(42):969-75. PubMed ID: 5114558 [No Abstract] [Full Text] [Related]
8. [Action of an extractive heparinoid on some blood coagulation indices]. Guidi G, Lombardi V, Torsellini A. Minerva Med; 1969 Dec 12; 60(99 Suppl):5034-8. PubMed ID: 4188587 [No Abstract] [Full Text] [Related]
12. Fibrinogen turnover and drugs acting on fibrinolysis. De Nicola P. Acta Univ Carol Med Monogr; 1972 Dec 12; 52():25-31. PubMed ID: 4544612 [No Abstract] [Full Text] [Related]
14. [Clearing and anti-platelet-aggregation effects of a heparinoid of natural origin]. Marini U, Bastoni F, Gibelli A. Clin Ter; 1974 Oct 15; 71(1):13-31. PubMed ID: 4138995 [No Abstract] [Full Text] [Related]
17. [On the therapeutic indication of SP 54 based on clinical experimental studies]. Hammerl H, Kränzl C, Pichler O, Studlar M. Med Welt; 1967 Mar 18; 11():638-45. PubMed ID: 4172234 [No Abstract] [Full Text] [Related]
18. [The effects of oral administration of a sulfo-polysaccharide of low molecular weight in a group of sedentary workers with ateriosclerotic cardiovascular disease]. Alessandri M, Fiorentini P, Garagnani C. G Clin Med; 1967 Sep 18; 48(9):935-47. PubMed ID: 4180085 [No Abstract] [Full Text] [Related]
19. [Use of the thromboelastograph for registration of the time of euglobulin lysis in normal rats and those with experimentally modified fibrinolysis]. Prino G, Mantovani M, Butti A. Farmaco Prat; 1969 Sep 18; 24(9):552-61. PubMed ID: 4187112 [No Abstract] [Full Text] [Related]
20. [Shifts in coagulating and fibrinolytic activity of the blood following the administration of nerobol in patients with coronary atherosclerosis]. Kratovskaia OV, Zalaldinova NB, Afaunova VI, Denisova TP, Lebedeva SN. Ter Arkh; 1972 Sep 18; 44(9):29-31. PubMed ID: 4660396 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]